Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-9,710
Closed -$279K 331
2024
Q4
$279K Sell
9,710
-40,251
-81% -$1.16M 0.01% 313
2024
Q3
$1.4M Sell
49,961
-27,039
-35% -$721K 0.03% 236
2024
Q2
$1.86M Buy
+77,000
New +$1.89M 0.05% 203
2024
Q1
Sell
-8,794
Closed -$244K 518
2023
Q4
$244K Buy
+8,794
New +$228K 0.01% 395

Other funds holding ALKS

UBS O'Connor's ALKS Position: Q1 2025 in Review

UBS O'Connor sold out of Alkermes (ALKS) in Q1 2025, closing a stake of 9,710 shares — an estimated $279K sold.

UBS O'Connor first reported a position in ALKS in Q4 2023 and held it in 4 quarters. The position peaked at $1.86M in Q2 2024. 371 funds tracked by Wall St. Rank hold ALKS as of Q1 2025.

  • UBS O'Connor reported no remaining Alkermes position as of Q1 2025 after selling out during the quarter.
  • UBS O'Connor sold 9,710 Alkermes shares in Q1 2025, an estimated $279K.
  • UBS O'Connor first reported a position in Alkermes in Q4 2023 and held it in 4 quarters.
  • UBS O'Connor's Alkermes position peaked at $1.86M in Q2 2024.
  • 371 funds tracked by Wall St. Rank held Alkermes as of Q1 2025.

Based on UBS O'Connor's 13F filing for Q1 2025, filed 15 May 2025.